Hi ozdog. Fair call.
But I think a trade name does not necessarily have to incorporate the characteristics of the drug itself.
An example is "Zolvix", which is the trade name of monepantel for livestock use.
The trade name should be a unique identifier that is not to be confused with any other product.
My original suggestion was based on this line of thought. However, in retrospect it seems a bit clunky.
Perhaps shortening it to "Sasquol" might make it a bit more snappy.
I agree with you that 7 News seems to have a new disease "breakthrough" treatment almost every night. I think that if and when our MND trial succeeds it will be front page headline news rather than just another lifestyle segment filler.
Cheers, Thrifty
Hi ozdog. Fair call.But I think a trade name does not...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.010(4.00%) |
Mkt cap ! $94.80M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 23.5¢ | $140.9K | 586.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12010 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 70000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
23.5¢ |
Change
-0.010 ( 4.08 %) |
||||
| Open | High | Low | Volume | ||
| 24.0¢ | 24.5¢ | 23.5¢ | 164909 | ||
| Last updated 15.58pm 26/04/2024 ? | |||||
| PAA (ASX) Chart |